Information was received from a healthcare provider (hcp) via a company representative regarding a patient receiving gablofen (2000 mcg/ml at 1050 mcg/day) via an implanted pump.The patient¿s medical history included anoxic brain injury, non-verbal, quadriplegia, and vent dependent.The indication for pump use was head/brain injury and intractable spasticity.It was reported that the patient developed an infection at the pump pocket.The environmental, external, or patient factor that may have led or contributed to the issue was noted to be that the patient had a j tube procedure done on (b)(6) 2021 and had cellulitis over parts of his body since then and now the pump was looking closer to the skin and swollen.To patient was taken to the or (operating room) on (b)(6) 2021 to explore the system.During the procedure, the pump was externalized and going to be used bedside to wean the baclofen dose while bridging to orals.Additional information was received on 09-dec-2021 at which time it was reported that the pump was being used at the patient¿s bedside attached to an externalized spinal catheter.The team was programming the pump over a week-long weaning protocol while bridging the patient to oral medications.The plan then was to remove the catheter.The hcp was planning to discard both the pump and catheter because there was never a suspected problem with the pump or catheter.The current dose of the pump was 440 mcg/day.The patient was stable thus far with increasing doses of oral baclofen, cyproheptadine and diazepam.
|